Citadel Advisors’s Aceragen Inc ACGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,584
Closed -$28K 15130
2021
Q3
$28K Sell
1,584
-553
-26% -$9.97K ﹤0.01% 13590
2021
Q2
$44K Sell
2,137
-7,714
-78% -$155K ﹤0.01% 13384
2021
Q1
$217K Buy
+9,851
New +$738K ﹤0.01% 11541
2018
Q1
Sell
-99
Closed -$28K 8949
2017
Q4
$28K Buy
+99
New +$28.3K ﹤0.01% 7776
2017
Q2
Sell
-107
Closed -$36K 8238
2017
Q1
$36K Buy
+107
New +$25.8K ﹤0.01% 7121
2016
Q1
Sell
-103
Closed -$43K 8263
2015
Q4
$43K Buy
103
+18
+21% +$8.05K ﹤0.01% 7430
2015
Q3
$39K Sell
85
-106
-55% -$46.9K ﹤0.01% 7755
2015
Q2
$96K Buy
191
+117
+158% +$53.7K ﹤0.01% 7118
2015
Q1
$37K Buy
74
+73
+7,300% +$44.5K ﹤0.01% 7578
2014
Q4
$1K Sell
1
-109
-99% -$43.7K ﹤0.01% 8426
2014
Q3
$34K Sell
110
-76
-41% -$27.4K ﹤0.01% 7141
2014
Q2
$73K Sell
186
-259
-58% -$107K ﹤0.01% 6473
2014
Q1
$247K Buy
+445
New +$305K ﹤0.01% 5269

Other funds holding ACGN

Citadel Advisors's ACGN Position: Q1 2023 in Review

Citadel Advisors sold out of Aceragen Inc (ACGN) in Q1 2023, closing a stake of 2,960 shares — an estimated $17.6K sold.

Citadel Advisors first reported a position in ACGN in Q1 2014 and held it in 26 quarters. The position peaked at $673K in Q1 2014. 19 funds tracked by Wall St. Rank hold ACGN as of Q1 2023.

  • Citadel Advisors reported no remaining Aceragen Inc position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 2,960 Aceragen Inc shares in Q1 2023, an estimated $17.6K.
  • Citadel Advisors first reported a position in Aceragen Inc in Q1 2014 and held it in 26 quarters.
  • Citadel Advisors's Aceragen Inc position peaked at $673K in Q1 2014.
  • 19 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.